Form 4 for OCGN Ocugen, Inc.
Accepted 2021-10-22 00:00:00 ET · period of report 2021-10-21 · accession 0001882178-21-000034 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2021-10-22 | 2021-10-21 | OCGN | Kompella Uday | Dir | S - Sale | $9.01 | -1,898 | 275.8K | -0.7% | -$17.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-21 | S | D | 1,898 | $9.01 | 275,787 | I By: Kompella LLC | — | — | (F1) This sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $9.00 to $9.02. The Reporting Person undertakes to provide to Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |